TY - JOUR
T1 - Persistent pain is associated with poorer balance and gait performance for people with Chronic Obstructive Pulmonary Disease
AU - Loughran, Kirsti Jane
AU - Trewartha, Grant
AU - Martin, Denis
AU - Fernandes-James, Caroline
AU - Shea, Rebecca
AU - Dixon, John
AU - Tough, Daniel
AU - Harrison, Samantha Louise
N1 - Publisher Copyright:
© 2025 The Authors
PY - 2025/7/1
Y1 - 2025/7/1
N2 - Background: People with COPD fall due to balance and gait impairments, and frequently report pain. The influence of pain on balance and gait in people with COPD is unknown. We aimed to compare balance and gait in people with COPD with and without persistent pain and explore factors associated with poor balance and gait. Methods: 43 participants’ characteristics and pulmonary rehabilitation outcomes were recorded. Participants were assigned to two groups, those with persistent pain (pain lasting ≥3months) (n = 25) and those without (n = 18) for analysis. Between-group differences were calculated for pain (BPI-SF), balance (BESTest, BBS), gait (GAITrite), isokinetic hip, knee and ankle strength (MVC), lower limb muscle endurance (30 s STS), physical activity (PASE) and Maximal Inspiratory Pressure (Pimax). Associations between neuromuscular factors and balance/gait outcomes were investigated. Results: BESTest and BBS scores were 14.0 % (95 % CI: 7.4–20.6) and 3.0 (95 % CI: 0.7–5.3) lower, for the persistent pain group. Mean gait speed was slower for the pain group (0.99 m/s vs 1.18 m/s, 95 %CI for difference: 0.03–0.35 m/s, group main effect: p = 0.02). The mean reduction in dual-task vs single-task gait speed was greater in the pain group (0.12 m/s vs 0.05 m/s, interaction effect: p = 0.045). Lower BESTest scores were associated with poorer muscle endurance (r = 0.650), pain severity (r = −0.584), and weaker hip abductors (r = 0.370) and ankle plantar-flexors (r = 0.438). No associations were apparent for gait speed. Conclusion: People with COPD plus pain have worse balance and slower gait speed, especially under dual-task conditions. Pain severity, muscle endurance and hip and ankle strength are associated with balance performance.
AB - Background: People with COPD fall due to balance and gait impairments, and frequently report pain. The influence of pain on balance and gait in people with COPD is unknown. We aimed to compare balance and gait in people with COPD with and without persistent pain and explore factors associated with poor balance and gait. Methods: 43 participants’ characteristics and pulmonary rehabilitation outcomes were recorded. Participants were assigned to two groups, those with persistent pain (pain lasting ≥3months) (n = 25) and those without (n = 18) for analysis. Between-group differences were calculated for pain (BPI-SF), balance (BESTest, BBS), gait (GAITrite), isokinetic hip, knee and ankle strength (MVC), lower limb muscle endurance (30 s STS), physical activity (PASE) and Maximal Inspiratory Pressure (Pimax). Associations between neuromuscular factors and balance/gait outcomes were investigated. Results: BESTest and BBS scores were 14.0 % (95 % CI: 7.4–20.6) and 3.0 (95 % CI: 0.7–5.3) lower, for the persistent pain group. Mean gait speed was slower for the pain group (0.99 m/s vs 1.18 m/s, 95 %CI for difference: 0.03–0.35 m/s, group main effect: p = 0.02). The mean reduction in dual-task vs single-task gait speed was greater in the pain group (0.12 m/s vs 0.05 m/s, interaction effect: p = 0.045). Lower BESTest scores were associated with poorer muscle endurance (r = 0.650), pain severity (r = −0.584), and weaker hip abductors (r = 0.370) and ankle plantar-flexors (r = 0.438). No associations were apparent for gait speed. Conclusion: People with COPD plus pain have worse balance and slower gait speed, especially under dual-task conditions. Pain severity, muscle endurance and hip and ankle strength are associated with balance performance.
UR - http://www.scopus.com/inward/record.url?scp=105004271239&partnerID=8YFLogxK
U2 - 10.1016/j.rmed.2025.108133
DO - 10.1016/j.rmed.2025.108133
M3 - Article
AN - SCOPUS:105004271239
SN - 0954-6111
VL - 243
SP - 108133
JO - Respiratory Medicine
JF - Respiratory Medicine
M1 - 108133
ER -